Anzeige
Mehr »
Mittwoch, 16.07.2025 - Börsentäglich über 12.000 News
Klinisch validiert. Vertriebsbereit. Und kurz vor der FDA-Zulassung.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PKMZ | ISIN: US6700024010 | Ticker-Symbol: NVV1
Tradegate
15.07.25 | 21:41
5,848 Euro
-2,17 % -0,130
1-Jahres-Chart
NOVAVAX INC Chart 1 Jahr
5-Tage-Chart
NOVAVAX INC 5-Tage-Chart
RealtimeGeldBriefZeit
5,8405,96015.07.
5,9045,96515.07.

Aktuelle News zur NOVAVAX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SoNovavax Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten!
DoCiti Initiates Coverage of Novavax (NVAX) With a Sell Rating29
25.06.Novavax Sees Sanofi Vaccine Pact as Model for Future Deals, Some Going Beyond Infectious Disease88
24.06.NOVAVAX INC - 8-K, Current Report37
NOVAVAX Aktie jetzt für 0€ handeln
22.06.Notable healthcare headlines for the week: Eli Lilly, Novavax and Sarepta Therapeutics in focus57
17.06.Novavax slips as Citi launches with Sell rating on pipeline concerns66
17.06.Citi initiates Novavax stock with sell rating on strategy shift concerns43
12.06.Novavax's COVID-Flu Combo Shot Shows Strong Immune Response42
11.06.Novavax auf Goldman Sachs Healthcare Konferenz: Strategische Neuausrichtung auf F&E70
11.06.Novavax's Experimental COVID-19-Influenza Combo Shot Shows Immune Response Among Older Adults In Phase 3 Trial12
11.06.US-Vorbörse: Tesla, Victoria's Secret, Novavax, Chewy und Gitlab mit viel Bewegung24
11.06.Tesla, Victoria's Secret, Novavax rise premarket; Chewy, Gitlab fall23
11.06.Novavax posts immune data to back COVID-flu combo shot and standalone flu shot6
11.06.Novavax: CIC And Flu Vaccine Candidates Induce Immune Responses Similar To Licensed Comparators537WASHINGTON (dpa-AFX) - Novavax, Inc. (NVAX) reported results of the initial cohort of COVID-19-Influenza Combination and stand-alone trivalent hemagglutinin nanoparticle seasonal influenza Phase...
► Artikel lesen
11.06.Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study6
11.06.NOVAVAX INC - 8-K, Current Report6
11.06.Novavax, Inc.: Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial231Both vaccine candidates induced robust immune responses across all antigens tested No new safety signals were observed and both vaccine candidates were well tolerated consistent with...
► Artikel lesen
22.05.Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More72
20.05.Healthy Returns: Novavax scores narrower Covid vaccine approval after delay54
20.05.JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News97
Weiter >>
167 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,14